Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Neon Therapeutics
4127
Neon Therapeutics
Health Care
Technology
Biotechnology
Neon Therapeutics is an immunooncology company focused on developing novel therapeutics leveraging neoantigen biology to treat cancer.
Suggest edits
Type
B2c
Founded
2015
Raised
$161M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
General Catalyst
Akamai
Companies in the same industry
Benchling
Cambridge Cancer Genomics
Procept BioRobotics
Ikarovec
Copan Diagnostics
Berkeley Launch
DiogenX
Vico Therapeutics
Inspire Medical Systems
BioDigital
Alexa global traffic share
Overview
Funding
3
Add info
Latest funding
Show all
$36,000,000
Venture capital (Series B) - 2017
Access Industries
Hillhouse Capital Group
Wellington Management
+6
$70,000,000
Venture capital (Series B) - 2017
Access Industries
Wellington Management
Fidelity Management and Research Company
+4
Team Size
10+
Employees
I work here
Location
Cambridge
,
United States
Headquarters
Explore Cambridge
Xconomy
Cancer Drug Developer BioNTech to Buy Neon Therapeutics in $67M Deal
PE HUB
VC-backed Neon Therapeutics goes public
Stock markets
Costs
Health
Xconomy
Neon Therapeutics Hauls in $70M for Personalized Cancer Vaccines
Health
Science
$70,000,000
Venture capital (Series B)
businesswire
Neon Therapeutics Secures $70 Million in Series B Financing | Business Wire
$55,000,000
Venture capital (Series A)
FinSMEs
Neon Therapeutics Raises $55M Series A Financing
